This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's Early Winners & Losers

Cheesecake Factory (CAKE - Get Report) shares were leaping after the restaurant chain said that, based on preliminary results, comparable sales had risen a total of 0.8%, with a 0.4% rise for its Cheesecake Factory restaurants and a 7.8% climb in its secondary Grand Lux Cafe chain. It also said fourth-quarter sales have likely grown 18% from a year ago (on a 13-week basis) to $360.4 million, which tops the Street's view by about $6.4 million. Shares of the Calabasas Hills, Calif., company were up $1.63, or 6.6%, to $26.19.

Vascular Solutions (VASC - Get Report) rose on word that the FDA had granted 501(k) safety clearance to the Minneapolis-based company's InnerChange micro-introducer catheter product. InnerChange allows physicians to inject the solution necessitated by diagnostic angiograms (X-rays of blood vessels) using a single micro-access needle stick. The company expects to begin its preliminary evaluations for launching the product sometime in January. Shares were gaining 38 cents, or 4.2%, to $9.38.

Emageon (EMAG) fell after the Birmingham, Ala.-based business-software company forecast 2007 sales between $136 million and $140 million, at least $23.4 million below the consensus. Earnings are pegged at $5.3 million and $6.5 million, or 24 cents to 29 cents a share; excluding items, they will likely range between 79 cents and 87 cents. Shares were sliding 94 cents, or 6.7%, to $13.00.

ScanSource (SCSC - Get Report) dropped as the technology-products distributor issued disappointing fourth-quarter guidance. The Greenville, S.C., company expects to take in revenue between $467 million and $475 million. Analysts are looking for $489.4 million. Shares were losing $1.58, or 5.2%, to $28.55.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
EMAG $21.54 -1.61%
CAKE $53.70 -1.53%
OSIR $19.56 0.51%
SCSC $38.45 1.02%
S $4.52 -0.88%

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs